← Back to Search

Integrated Machine Learning Approach for High Cholesterol (BEAT FH Trial)

N/A

Waitlist Available

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

BEAT FH Trial Summary

This trial aims to find those at high risk of familial hypercholesterolemia and encourage diagnosis and treatment. Three phases will help make it happen.

Who is the study for?

This trial is for patients at Penn Medicine who are identified by the FIND FH tool as likely having Familial Hypercholesterolemia (FH), but have not been clinically diagnosed with it. It's aimed at those who may be at high risk of this condition, which involves very high cholesterol levels.Check my eligibility

What is being tested?

The study tests new ways to find and manage FH using a machine learning tool within electronic health records. It includes refining referral processes for primary care providers and exploring patient outreach methods across three phases: data gathering, pilot development, and a large-scale pragmatic trial.See study design

What are the potential side effects?

Since this trial focuses on diagnosis and management strategies rather than medication or medical procedures, traditional side effects are not applicable. However, there might be indirect consequences related to changes in clinical management practices.

BEAT FH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of actual patient visits with a lipid specialist

Rate of referrals to preventive cardiology

BEAT FH Trial Design

2Treatment groups

Active Control

Group I: Patients with a primary care physician within the UPHS health systemActive Control2 Interventions

Pilot 2 is examining ways to increase physician referrals to preventive cardiology, and increase patient visits with a lipid specialist for a formal evaluation of FH.

Group II: Patients without a primary care physician within the UPHS health systemActive Control1 Intervention

Pilot 1 is examining ways to get patients without a primary care physician within the UPHS health system to schedule a visit with a lipid specialist for a formal evaluation of FH.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Family Heart FoundationUNKNOWN

2 Previous Clinical Trials

822 Total Patients Enrolled

Northwestern UniversityOTHER

1,585 Previous Clinical Trials

917,151 Total Patients Enrolled

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,880,008 Total Patients Enrolled

Media Library

Patients with a primary care physician within the UPHS health system Clinical Trial Eligibility Overview. Trial Name: NCT05746247 — N/A

High Cholesterol Research Study Groups: Patients with a primary care physician within the UPHS health system, Patients without a primary care physician within the UPHS health system

High Cholesterol Clinical Trial 2023: Patients with a primary care physician within the UPHS health system Highlights & Side Effects. Trial Name: NCT05746247 — N/A

Patients with a primary care physician within the UPHS health system 2023 Treatment Timeline for Medical Study. Trial Name: NCT05746247 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in the trial currently available for participants?

"Data accessible on clinicaltrials.gov shows that this investigation, which was first posted March 1st 2022 and last updated February 17th 2023, is no longer recruiting participants. Nonetheless, 68 other trials are actively seeking enrolment at the present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Diagnosis and Clinical Management of Familial Hypercholesterolemia Through Integrated Machine Learning, Implementation Science, and Behavioral Economics

2022. "Improving Diagnosis and Clinical Management of Familial Hypercholesterolemia Through Integrated Machine Learning, Implementation Science, and Behavioral Economics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05746247.

All > Cholesterol